Milestone Pharmaceuticals Downgraded to Hold by Zacks Research

요약

“Zacks Research downgraded Milestone Pharmaceuticals from 'strong-buy' to 'hold' rating”
“Multiple analysts have recently issued mixed ratings on MIST stock”
“The stock currently holds average 'Hold' rating with $8.00 consensus price target”

Profit ▼ Debt high Cash good Valuation low Drawdown neutral Recent decline

Zacks Research, Milestone Pharmaceuticals 등급 '강력 매수'에서 '보유'로 하향
Zacks Research가 Milestone Pharmaceuticals의 등급을 '강력 매수'에서 '보유'로 하향 조정
최근 여러 애널리스트들이 MIST 주식에 대해 엇갈린 평가를 내림
현재 주식은 평균 '보유' 등급을 유지하며 컨센서스 목표 주가는 $8.00

출처: MarketBeat
링크: https://www.marketbeat.com/instant-alerts/zacks-research-downgrades-milestone-pharmaceuticals-nasdaqmist-to-hold-2026-02-26/

앱에서 게시글 열기

소셜 공유 미리보기(OG) 전용 페이지입니다.